The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

The new accelerated approval covers the use of Scemblix for newly diagnosed patients with Philadelphia chromosome-positive ...

Novartis has received US Food and Drug Administration (FDA) accelerated approval for Scemblix (asciminib) to treat adults ...

Apple's new hearing health features for the AirPods Pro could be a game-changer for those with hearing loss, but half of all ...

The two are improbable avatars of a campaign to restore America’s health, and some former Trump aides expressed skepticism ...

China's top lawmakers gathered Monday to hash out a major stimulus package that analysts say could grow even bigger if former ...

US FDA grants accelerated approval to Novartis’ Scemblix for adult patients with newly diagnosed Ph+ CML-CP: East Hanover Thursday, October 31, 2024, 12:00 Hrs [IST] Novartis an ...

For Finnish startup Solar Foods, getting FDA approval in September for their first ... “It gives you that…gold stamp to then go to market with,” Roberts says. Especially where consumers ...

Public health experts have credited vaccination as the single greatest public health achievement of the 20th century, ...

The quest for youthful energy and vitality often leads to dietary supplements that promise a renewed sense of well-being. One ...